IL1B and major depressive disorder: The NBP treatment group has higher levels of both SOD and catalase (CAT), and lower levels of both MDA and proinflammatory cytokine (IL-1β and IL-6) were found in major depressive disorder (MDD) rats [26], diabetic rats [125], EAM guinea pigs [14], and BMSCs [95].